The Collaborative Centre for Applied Nanotechnology (CCAN) is an industry-led, collaborative, applied research centre enabling its member companies and research providers to work together to develop nanotechnology-enabled products and solutions for the ICT and biomedical industries.
Organisations currently active members of CCAN include indigenous SME’s, multinational corporations from both the ICT and medical device industries and research institutes from across Ireland.
The founding Industry Members were Aerogen, Analog Devices, Audit Diagnostics, Creganna-Tactx, Intel, Medtronic, Proxy Biomedical and Seagate.
The centre is hosted by Tyndall National Institute at UCC and CRANN at TCD with research partners from NUI Galway , DCU and the School of Pharmacy at UCC who are contracted to perform research activities as part of the Research Programme.
For more information on how to interact with CRANN and CCAN please go to www.ccan.ie
The CCAN network offers nanoscience and nanotechnology expertise to assist all members in their development activities enabling members to work together to overcome product development challenges faster by exploiting their combined expertise.
Membership of CCAN enables members to participate in and benefit from the Research Programme, which is comprised of various research projects undertaken to develop and demonstrate the adoption and exploitation of nanotechnology for the economic benefit of the Industry Members.
CCAN members enjoy the following entitlements and benefits from their active involvement in the centre.
Generate greater and faster returns from their R&D activities hence increasing competitiveness
Access the combined expertise of the centre to resolve development issues
Network with other leading companies and develop new business relationships
Leverage CCAN core funding for technology development aligned with their strategic roadmaps
Secure additional funding from outside centre to accelerate research programs
Use research capabilities from multiple universities all focused on the delivery of the best outcome for the member companies
Benefit from an industry-led, efficient, low overhead model for engaging in applied nanotechnology research
Drive innovation by overlapping competencies from different markets and partners.